Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article.
aINSERM, Imagerie cérébrale et handicaps neurologiques, Toulouse, France
bUniversité de Toulouse, Imagerie cérébrale et handicaps neurologiques, Toulouse, France
cDepartment of Neurology, University Hospital of Toulouse, Toulouse, France
dINSERM, Clinical Investigation Center, Purpan, Toulouse, France
eDepartment of Neurosurgery, University Hospital of Toulouse, Toulouse, France
fDepartment of Clinical Pharmacology, University of Medicine, Toulouse, France
*Corresponding author. Address: INSERM U825, Pavillon Baudot, CHU Purpan, 31059 Toulouse, France. Tel.: +33 05 81 18 49 84.
E-mail address:[email protected]
Article history: Received 10 February 2012; Received in revised form 18 July 2012; Accepted 24 July 2012.